Acer Therapeutics Inc
ACER
ACER was delisted on the 8th of November, 2023.
30 hedge funds and large institutions have $4.47M invested in Acer Therapeutics Inc in 2021 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 5 increasing their positions, 10 reducing their positions, and 4 closing their positions.
0% more funds holding
Funds holding: 30 → 30 (0)
0% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 4
13% less capital invested
Capital invested by funds: $5.15M → $4.47M (-$675K)
50% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 10
67% less call options, than puts
Call options by funds: $38K | Put options by funds: $116K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
State Street
Boston,
Massachusetts
|
+$71.8K |
| 2 |
XT
XTX Topco
George Town,
Cayman Islands
|
+$54K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$46.4K |
| 4 |
Millennium Management
New York
|
+$33K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$31.9K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Squarepoint
New York
|
-$233K |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$176K |
| 3 |
VF
Virtu Financial
New York
|
-$55K |
| 4 |
Barclays
London,
United Kingdom
|
-$24K |
| 5 |
Simplex Trading
Chicago,
Illinois
|
-$20.4K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
26
Squarepoint
New York
| – | -$233K | -75,014 | Closed |
|
|
27
Citadel Advisors
Miami,
Florida
| – | -$176K | -61,308 | Closed |
|
|
VF
28
Virtu Financial
New York
| – | -$55K | -17,646 | Closed |
|
|
29
Barclays
London,
United Kingdom
| – | -$24K | -7,737 | Closed |
|
30
Wells Fargo
San Francisco,
California
| – | -$3 | -1 | -2% |
|
31
Bank of America
Charlotte,
North Carolina
| – | +$150 | +52 | New |
|
ACER Hedge Fund Activity: Q2 2021 in Review
30 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Acer Therapeutics Inc (ACER) for Q2 2021, worth a combined $4.47M — down 13% from $5.15M a quarter earlier.
Fund positioning in ACER was balanced in Q2 2021: 4 funds opened new positions, 4 closed out, 5 added to existing stakes and 10 trimmed.
The largest buyer was State Street, opening a new position worth an estimated $71.8K. The largest seller was Squarepoint, exiting entirely with an estimated $233K sold.
- 30 institutional investors held Acer Therapeutics Inc (ACER) as of Q2 2021, unchanged from Q1 2021.
- Funds reported $4.47M of Acer Therapeutics Inc stock for Q2 2021, down 13% quarter-over-quarter.
- 4 funds opened new Acer Therapeutics Inc positions in Q2 2021 and 4 closed out, a net change of 0 holders.
- The largest Acer Therapeutics Inc buyer in Q2 2021 was State Street, an estimated $71.8K added.
- The largest Acer Therapeutics Inc seller in Q2 2021 was Squarepoint, an estimated $233K sold.
Based on aggregated 13F filings for Q2 2021.